Classical Hodgkin Lymphoma
![Advanced Classical Hodgkin Lymphoma: BrECADD Shows Noninferiority to eBEACOPP](https://pharmtales.com/wp-content/uploads/2023/06/Advanced-Classical-Hodgkin-Lymphoma_-BrECADD-Shows-Noninferiority-to-eBEACOPP.jpg)
Advanced Classical Hodgkin Lymphoma: BrECADD Shows Noninferiority to eBEACOPP
SG Tylor
Source – BrECADD According to information from the Phase III HD21 trial (NCT02661503), which included patients with advanced classical Hodgkin ...
![98% ORR in Early-Stage Classical Hodgkin Lymphoma with Brentuximab Vedotin + Nivolumab/Chemo](https://pharmtales.com/wp-content/uploads/2023/06/98-ORR-in-Early-Stage-Classical-Hodgkin-Lymphoma-with-Brentuximab-Vedotin-Plus-Nivolumab_Chemo.jpg)
98% ORR in Early-Stage Classical Hodgkin Lymphoma with Brentuximab Vedotin + Nivolumab/Chemo
SG Tylor
Source – Seagen Frontline treatment with the combination of brentuximab vedotin (Adcetris), nivolumab (Opdivo), doxorubicin, and dacarbazine led to an ...